Stevanato Group S.p.A.

Stevanato Group S.p.A. provides drug containment, drug delivery, and diagnostic solutions, alongside manufacturing engineering systems for the pharmaceutical, biotechnology, and life sciences industries. It operates through two primary segments: Biopharmaceutical and Diagnostic Solutions, which supplies products such as pre-fillable syringes, vials, cartridges, diagnostic consumables, and drug delivery devices; and Engineering, which designs visual inspection, assembly, packaging, and serialization machinery. The company primarily serves global pharmaceutical, biotechnology, and diagnostic businesses, supporting their drug product life cycles from research through commercial production.

Headquartered in Piombino Dese (Padua), Italy, the company distributes its products and services across approximately 65 countries worldwide. Its global infrastructure includes 13 manufacturing plants, comprising ten production facilities for biopharmaceutical and healthcare products and three plants dedicated to equipment and machinery, located in Italy, Germany, Slovakia, Brazil, Mexico, China, Denmark, and the United States. In addition, the firm maintains two analytical testing sites and five commercial offices globally.

Summary of the business section of Stevanato Group S.p.A.'s latest annual report, written by StockData.

“As of December 31, 2025, we employed 6,010 employees in multiple jurisdictions (approximately 58% based in Italy, 10% based in Germany, 8% based in the U.S., 7% based in Mexico, 5% based in Brazil, 4% based in each Slovakia, and Denmark, and 3% based in China).”